Evidence map›Paper›PMID 32801646›Full record

ArticleDrug design, development and therapy2020

Antibacterial of Dibenzo-

Dikdik Kurnia, Putri Rachmawati, Mieke H Satari

Abstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. A newly discoveredFrontiers in microbiology · 2026
    Article
  3. Journal of conservative dentistry and endodontics · 2025
    Article
  4. Article
  5. Exploring the Inhibitory Potential ofTheScientificWorldJournal · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dikdik KurniaDepartment of Chemistry, Faculty of Mathematics and Natural Science, Universitas Padjadjaran, Sumedang, Indonesia.ORCID 0000-0001-9789-9785
Putri RachmawatiDepartment of Chemistry, Faculty of Mathematics and Natural Science, Universitas Padjadjaran, Sumedang, Indonesia.ORCID 0000-0001-7461-8573
Mieke H SatariDepartment of Oral Biology, Faculty of Dentistry, Universitas Padjadjaran, Sumedang, Indonesia.ORCID 0000-0002-6021-9480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, it has emerged from the international scientific literature that quorum sensing (QS) is a promising way for the effective treatment of diseases caused by pathogenic bacteria. One of the crucial proteins in the QS system of Gram-positive bacteria is the pheromone. Some research has reported secondary metabolites from natural products capable of attenuating bacteria through the interruption of the quorum sensing system. One of the Indonesian herbal plants containing bioactive compounds is Sarang Semut (

aimThe study in question aimed to predict the molecular action of the compound MATERIALS AND

methodsThe methods used in this in silico study were ligand-protein docking and virtual screening that were performed by some software and programs. The compound

resultsIt was found thatcompound

conclusionIt is proposed that compound

Indexed as

Anti-Bacterial AgentsEnterococcus faecalisLigandsMicrobial Sensitivity TestsMolecular Docking SimulationMolecular StructureQuorum SensingRubiaceaeAnti-Bacterial AgentsLigandsCcfAoral bacteriapeptide pheromonesPrgQPrgXPrgZquorum sensing

Identifiers

PMID32801646
PMCPMC7398749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.